The FDA is stepping up its unannounced inspections of foreign manufacturing facilities.
In a statement about the increase in inspections, the Food and Drug Administration did not report how many inspections will be conducted. It is unclear how the number of inspections will be impacted by recent staff cuts at
Continue Reading FDA plans to increase inspections of foreign facilities; few details released
The U.S. Food and Drug Administration is extending its application period for its Voluntary Qualified Importer Program (VQIP) to July 31. The application extension is because of the COVID-19 public health emergency and current travel restrictions and advisories.
The importer program is a voluntary fee-based program that provides expedited review
Continue Reading FDA extends application period for importer program because of pandemic
